OTraces, Inc. Competitors

The Laboratory for Advanced Medicine, Inc. (LAM) is a bio-pharmaceutical company dedicated to developing revolutionary non-invasive, non-toxic technologies for disease diagnosis and intervention, with an emphasis on cancer. From research and development through commercial offerings, LAM is focused on building and growing world-class technologies geared towards detecting and treating disease at its earliest stage. LAM operates scientifically, ethically, and efficiently to bring these cutting-edge technologies from concept into mainstream medicine. LAM is headquartered in the United States with offices in California, Texas, and Indiana. LAM is a multinational business with collaborations in both the United States and China, including leading scientists, physicians, research institutions, and business leaders from both countries. LAM strives to combine the experiences of these innovators and achievers in order to provide the healthiest and safest diagnostic technologies to everyone. LAM has CLIA and CAP certified laboratories, 3rd party laboratories, and cGMP facilities all working towards the endeavor of bringing these first-class technologies into the medical community.

CellMax Life is a leading cancer diagnostics company whose mission is to transform how cancer is diagnosed and managed with globally affordable non-invasive tests for early cancer detection and management. CellMax’s unique expertise in both Circulating Tumor Cell and Next Generation Sequencing of DNA and circulating tumor DNA (ctDNA) has enabled multiple highly effective precision medicine solutions for healthy people as well as patients diagnosed with cancer.

BioFluidica® is a biotechnology company dedicated to eliminating obstacles to the adoption of liquid biopsy as a tool for researchers and clinicians. We combine cutting-edge microfluidics, advanced immunoaffinity chemistries, automation hardware, and workflow optimizations to improve sensitivity and specificity, increase throughput, and enable the isolation and enrichment of multiple disease biomarkers from a single sample.